Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortOnce-daily inhaled LAMA for COPD, also in triple inhalers.Once-daily inhaler that keeps airways open in COPD.
Body systemLungs & BreathingLungs & Breathing
Drug classLong-acting antimuscarinicsLong-acting antimuscarinics
SupplyPrescription onlyPrescription onlyWHO essential medicine
Main usesCOPD maintenanceCOPD maintenance, Severe asthma (add-on)
How it worksRelaxes the airways by blocking a nerve signal that narrows them.Blocks the nerve signal that tightens your airways, for 24 hours.
Starts workingWithin 15 minutes—
Half-lifeAbout 11 hours5–6 days
Typical adult dose55 micrograms (1 inhalation) once a day.Respimat: 2 puffs (5 micrograms) once a day. HandiHaler: 18 micrograms once a day.
FormsDry-powder inhalerSoft mist inhaler, Dry powder capsule inhaler
Common side effectsCough, Sore throat, Headache, ConstipationDry mouth, Constipation, Cough
Serious side effectsNarrow-angle glaucoma worsening, Urinary retention, Fast heart rateUrinary retention, Acute angle-closure glaucoma (if sprayed in eyes)
Don't take ifNarrow-angle glaucoma (caution); Urinary retention (caution)—
AlcoholUsually no problem in moderation. No specific interaction.—
PregnancyUse with cautionLimited data; use only if needed.Use with cautionLimited data.
BreastfeedingUse with cautionLimited data.—
In use since—2002
Brand namesUnited States: Incruse Ellipta, Anoro Ellipta, Trelegy ElliptaUnited Kingdom: Incruse, Anoro, TrelegyIndia: Incruse, TrelegyUnited States: Spiriva HandiHaler, Spiriva RespimatUnited Kingdom: Spiriva, BraltusIndia: Tiova
Legal statusUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H—
ATC codeR03BB07R03BB04

Taken together

No interaction between these medicines is recorded in the atlas.

Open in the interaction checker